Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Accenture
US Army
Covington
Citi
QuintilesIMS
Moodys
US Department of Justice
Deloitte

Generated: April 24, 2018

DrugPatentWatch Database Preview

MEGACE Drug Profile

« Back to Dashboard

When do Megace patents expire, and when can generic versions of Megace launch?

Megace is a drug marketed by Bristol Myers Squibb and Endo Pharms Inc and is included in three NDAs. There are six patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in MEGACE is megestrol acetate. There are eighteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the megestrol acetate profile page.
Drug patent expirations by year for MEGACE
Pharmacology for MEGACE
Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Medical Subject Heading (MeSH) Categories for MEGACE
Synonyms for MEGACE
(1S,2R,10R,11S,14R,15S)-14-ACETYL-2,8,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-6,8-DIEN-14-YL ACETATE
(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
14365-EP2311464A1
14365-EP2316836A1
17-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione
17-Acetoxy-6-methylpregna-4,20-dione
17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione
17-alpha-Acetoxy-6-dehydro-6-methylprogesterone
17-Hydroxy-6-methylpregna-4,20-dione acetate
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate
17.alpha.-Acetoxy-6-dehydro-6-methylprogesterone
17.alpha.-Acetoxy-6-methyl-4,20-dione
17.alpha.-Acetoxy-6-methylpregna-4,20-dione
17alpha-Acetoxy-6-dehydro-6-methylprogesterone
17alpha-Acetoxy-6-methylpregna-4,6-diene-3,20-dione
17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate
51154-23-5
595-33-5
595M335
6-Dehydro-6-methyl-17-alpha-acetoxyprogesterone
6-Dehydro-6-methyl-17.alpha.-acetoxyprogesterone
6-Dehydro-6-methyl-17alpha-acetoxyprogesterone
6-Methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione
6-Methyl-17-alpha-hydroxy-delta(sup 6)-progesterone acetate
6-Methyl-17.alpha.-hydroxy-.delta.(sup 6)-progesterone acetate
6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate
6-Methyl-3,20-dioxopregna-4,6-dien-17-yl acetate
6-Methyl-6-dehydro-17-alpha-acetoxyprogesterone
6-Methyl-6-dehydro-17.alpha.-acetoxyprogesterone
6-Methyl-6-dehydro-17.alpha.-acetylprogesterone
6-Methyl-6-dehydro-17alpha-acetoxyprogesterone
6-Methyl-delta(sup 4,6)-pregnadien-17-alpha-ol-3,20-dione acetate
6-Methyl-delta(sup 6)-dehydro-17-alpha-acetoxyprogesterone
6-Methyl-delta4,6-pregnadien-17alpha-ol-3,20-dione acetate
AB00383046_16
AB00383046-13
AB00383046-14
AB00383046-15
AB00490013
AB2000040
AC-24570
AC1L1XW9
AJ-47998
AK145584
AKOS015894927
Ambap595-33-5
AN-21566
ANW-43468
API0003279
AS-13384
B1377
BCP9000904
BCPP000168
BDH 1298
BDH-1298
BDH-1298, NSC-71423
BPBio1_001048
BRD-K19507340-001-03-1
BSPBio_000952
C08151
CAS-595-33-5
CCG-100899
CCRIS 372
CHEMBL1201139
CS-2065
CTK5B0088
D00952
DSSTox_CID_20683
DSSTox_GSID_40683
DSSTox_RID_79539
DTXSID9040683
EINECS 209-864-5
HMS1570P14
HMS2051I20
HMS2090N04
HMS2097P14
HMS2235D16
HY-13676
I040
LMST02030118
LS-118489
Magestin
Megace ES
Megace;Megace ES
Megeron
Megesgtrol Acetate, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Megestat
Megestrol (Acetate)
MEGESTROL ACETATE
Megestrol acetate (USAN)
Megestrol acetate [USAN:USP]
Megestrol acetate [USAN]
Megestrol acetate for peak identification, European Pharmacopoeia (EP) Reference Standard
Megestrol acetate for system suitability, European Pharmacopoeia (EP) Reference Standard
Megestrol acetate, analytical standard, for drug analysis
Megestrol acetate, European Pharmacopoeia (EP) Reference Standard
Megestrol acetate, United States Pharmacopeia (USP) Reference Standard
Megestrol acetate, VETRANAL(TM), analytical standard
Megestrol acetole
Megestrol acetole [Progestins]
Megestrol-17-acetate
MegestrolAcetate
Megestryl acetate
MFCD00056470
MLS000028633
MLS000759501
MLS001074091
MLS001424055
MolPort-005-934-820
NC00149
NCGC00016516-01
NCGC00024196-03
NCGC00024196-05
NCGC00255456-01
Niagestin
NSC-71423
NSC71423
Opera_ID_1511
Ovaban
Ovaban (Veterinary)
Ovarid
Pallace
par-100,2
PL057943
Pregna-4,20-dione, 17-(acetyloxy)-6-methyl-
Pregna-4,20-dione, 17-hydroxy-6-methyl-, acetate
Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-
Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-, acetate
Prestwick0_000956
Prestwick1_000956
Prestwick2_000956
Prestwick3_000956
Q-201346
RQZAXGRLVPAYTJ-GQFGMJRRSA-N
s1304
SC 10363
SC-10363
SC-16134
SC10363
SCHEMBL745
SMR000058691
SPBio_003101
TJ2M0FR8ES
Tox21_110469
Tox21_110469_1
Tox21_302360
TR-031797
UNII-TJ2M0FR8ES
WLN: L E5 B666 OV KU MUTJ A1 E1 FV1 FOV1 L1
ZINC4097467

US Patents and Regulatory Information for MEGACE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb MEGACE megestrol acetate SUSPENSION;ORAL 020264-001 Sep 10, 1993 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Endo Pharms Inc MEGACE ES megestrol acetate SUSPENSION;ORAL 021778-001 Jul 5, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Endo Pharms Inc MEGACE ES megestrol acetate SUSPENSION;ORAL 021778-001 Jul 5, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Endo Pharms Inc MEGACE ES megestrol acetate SUSPENSION;ORAL 021778-001 Jul 5, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for MEGACE
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Oral Suspension 125 mg/mL ➤ Subscribe 0000-00-00

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Teva
Harvard Business School
Citi
Cerilliant
Fuji
Argus Health
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.